1. Targeting the NF-E2-related factor 2 pathway: A novel strategy for glioblastoma (Review)
    JIANHONG ZHU et al, 2014 CrossRef
  2. A Rationale for Targeting Extracellular Regulated Kinases ERK1 and ERK2 in Glioblastoma
    Ricarda Hannen et al, 2017 CrossRef
  3. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma
    Chitrangda Srivastava et al, 2017, Int. J. Cancer CrossRef
  4. High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
    Olatz Arrizabalaga et al, 2017, Oncogenesis CrossRef
  5. Targeting Carbonic Anhydrase IX Activity and Expression
    Brian Mahon et al, 2015, Molecules CrossRef
  6. Role of metabolism in cancer cell radioresistance and radiosensitization methods
    Le Tang et al, 2018, J Exp Clin Cancer Res CrossRef
  7. Regulation of the oxidative balance with coenzyme Q10 sensitizes human glioblastoma cells to radiation and temozolomide
    Javier Frontiñán-Rubio et al, 2018, Radiotherapy and Oncology CrossRef
  8. Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines
    S. Giannattasio et al, 2018, J Endocrinol Invest CrossRef
  9. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo
    Carmela Ciccarelli et al, 2018, J Cancer Res Clin Oncol CrossRef
  10. CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer
    Hui Chang et al, 2018, Cancer Res Treat CrossRef
  11. Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
    Alessandro Fanzani, 0 CrossRef
  12. Malignant Intracranial High Grade Glioma and Current Treatment Strategy.
    Xiang Zhang et al, 2019, Curr Cancer Drug Targets CrossRef
  13. null
    Monica Mangoni et al, 2016 CrossRef
  14. Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation
    Francesco Marampon et al, 2019, IJMS CrossRef
  15. TNF‐α mediated MEK–ERK signaling in invasion with putative network involving NF‐κB and STAT‐6: a new perspective in glioma
    Palaniswamy Ramaswamy et al, 2019, Cell Biol Int CrossRef
  16. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells.
    Wanyeon Kim et al, 2015, Apoptosis CrossRef
  17. Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis
    F. Marampon et al, 2016, J Endocrinol Invest CrossRef
  18. Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.
    Dayle Rundle-Thiele et al, 2016, Br J Clin Pharmacol CrossRef
  19. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells
    Francesco Marampon et al, 2017, Cancer Letters CrossRef
  20. NFкB is a critical transcriptional regulator of atypical cadherin FAT1 in glioma
    Chitrangda Srivastava et al, 2020, BMC Cancer CrossRef
  21. Glioblastoma Stem Cells: Driving Resilience through Chaos.
    Briana C Prager et al, 2020, Trends Cancer CrossRef
  22. Cancer stem cells and signaling pathways in radioresistance
    Lei Chang et al, 2016, Oncotarget CrossRef
  23. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage
    Francesco Marampon et al, 2016, Oncotarget CrossRef
  24. A molecular view of the radioresistance of gliomas
    Xuetao Han et al, 2017, Oncotarget CrossRef
  25. Targeting hexokinase 2 enhances response to radio-chemotherapy in glioblastoma.
    Alenoush Vartanian et al, 2016, Oncotarget CrossRef
  26. β‑catenin nuclear translocation induced by HIF‑1α overexpression leads to the radioresistance of prostate cancer
    Yong Luo et al, 2018, Int J Oncol CrossRef
  27. Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent Genes
    Samuel Valable et al, 2020, Cancers CrossRef
  28. Inside the hypoxic tumour: reprogramming of the DDR and radioresistance
    Katheryn Begg et al, 2020, Cell Death Discov. CrossRef
  29. Radioresistance in Glioblastoma and the Development of Radiosensitizers
    Md Yousuf Ali et al, 2020, Cancers CrossRef
  30. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
    Faiqa Mudassar et al, 2020, J Exp Clin Cancer Res CrossRef
  31. Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response
    Emma McCann et al, 2021, Translational Oncology CrossRef
  32. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes
    Vipin Shankar Chelakkot et al, 2020, Sci Rep CrossRef
  33. The Role of Hypoxia in Glioblastoma Radiotherapy Resistance.
    Agathe L Chédeville et al, 2021, Cancers (Basel) CrossRef
  34. Diffuse Glioma Heterogeneity and Its Therapeutic Implications.
    James G Nicholson et al, 2021, Cancer Discov CrossRef
  35. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing
    Alexander E. Kabakov et al, 2021, Cancers CrossRef
  36. null
    Shivani Baisiwala et al, 2021 CrossRef
  37. Downregulation of both mismatch repair and non-homologous end-joining pathways in hypoxic brain tumour cell lines.
    Sophie Cowman et al, 2021, PeerJ CrossRef
  38. Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair
    Yu Zhang et al, 2021, Oncogene CrossRef
  39. Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas
    Kristina M. Cook et al, 2021, IJMS CrossRef
  40. Genome-wide CRISPR/Cas9 screening identifies CARHSP1 responsible for radiation resistance in glioblastoma
    Guo-dong Zhu et al, 2021, Cell Death Dis CrossRef
  41. Screening of MicroRNA Related to Irradiation Response and the Regulation Mechanism of miRNA-96-5p in Rectal Cancer Cells
    Fengpeng Wu et al, 2021, Front. Oncol. CrossRef
  42. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications
    Ritama Paul et al, 2021, Pharmacology & Therapeutics CrossRef
  43. Hypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy
    Andria Rakotomalala et al, 2021, Front. Endocrinol. CrossRef
  44. A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
    Feng Gao et al, 2021, Front. Oncol. CrossRef
  45. AMPK increases expression of ATM through transcriptional factor Sp1 and induces radioresistance under severe hypoxia in glioblastoma cell lines
    Takuma Hashimoto et al, 2021, Biochemical and Biophysical Research Communications CrossRef
  46. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies
    Ruiqi Li et al, 2022, Biomater. Sci. CrossRef
  47. Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
    Jang Hyun Park et al, 2022, Cancers CrossRef
  48. Depletion of HIF-1α by Inducible Cre/loxP Increases the Sensitivity of Cultured Murine Hepatocytes to Ionizing Radiation in Hypoxia
    Akram Hamidi et al, 2022, Cells CrossRef
  49. Hepatic Artery Embolization Induces the Local Overexpression of Transforming Growth Factor β1 in a Rat Hepatoma Model.
    Eisuke Ueshima et al, 2020, Liver Cancer CrossRef
  50. Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2/cyclin D1 signaling in esophageal squamous cell carcinoma
    Shau‐Hsuan Li et al, 2022, Journal Cellular Physiology CrossRef
  51. Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
    Shenghua Zhuo et al, 2022, Front. Mol. Biosci. CrossRef
  52. Cell cultures in assessing radioresistance of glioblastomas
    A.S. Belyashova et al, 2022, Vopr. neirokhir. CrossRef
  53. The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
    Lina Alhaddad et al, 2022, IJMS CrossRef
  54. Hypoxia Enhances Glioma Resistance to Sulfasalazine-Induced Ferroptosis by Upregulating SLC7A11 via PI3K/AKT/HIF-1α Axis
    Shicheng Sun et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
  55. Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
    Munazza Ahmed et al, 2022, IJMS CrossRef
  56. The Role of Hypoxia in Brain Tumor Immune Responses
    Jang Hyun Park et al, 2023, Brain Tumor Res Treat CrossRef
  57. Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?
    Pavel Burko et al, 2023, IJMS CrossRef
  58. Take my breath away: TAM-ing anti-cancer immunity in hypoxic niches
    Aylin Möckl et al, 2023, Immunity CrossRef
  59. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives angiotensin II-induced vascular remodeling through regulating mitochondrial fragmentation
    Litao Wang et al, 2023, Redox Biology CrossRef
  60. Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles
    Soo Yeon Kim et al, 2024, Brain Research CrossRef